21 CFR Part 50 · Protection of Human Subjects

§ 50.27 Documentation of informed consent

Subpart B - Informed Consent of Human Subjects Official text on eCFR Amendment history

(a) Except as provided in § 56.109(c) , informed consent shall be documented by the use of a written consent form approved by the IRB and signed and dated by the subject or the subject's legally authorized representative at the time of consent. A copy shall be given to the person signing the form.

(b) Except as provided in § 56.109(c) , the consent form may be either of the following:

(1) A written consent document that embodies the elements of informed consent required by § 50.25 . This form may be read to the subject or the subject's legally authorized representative, but, in any event, the investigator shall give either the subject or the representative adequate opportunity to read it before it is signed.

(2) A short form written consent document stating that the elements of informed consent required by § 50.25 have been presented orally to the subject or the subject's legally authorized representative. When this method is used, there shall be a witness to the oral presentation. Also, the IRB shall approve a written summary of what is to be said to the subject or the representative. Only the short form itself is to be signed by the subject or the representative. However, the witness shall sign both the short form and a copy of the summary, and the person actually obtaining the consent shall sign a copy of the summary. A copy of the summary shall be given to the subject or the representative in addition to a copy of the short form.

Independent copy, not an official legal edition. 21 CFR is a U.S. Government work in the public domain; this text comes from the eCFR and the annual CFR edition, and may lag recent amendments. The authoritative version is on ecfr.gov. Compliome is not affiliated with or endorsed by FDA. Not legal advice.

What FDA inspectors cite under § 50.27

Form FDA 483 observations citing this section, fiscal years 2009–2026 (Bioresearch Monitoring).

  • Consent form not approved/signed/dated 202
  • Copy of consent form not provided 18
  • Short form: Oral presentation/signing 7
  • Short form: IRB approval of oral presentation 5
  • Short form: Summary copy not signed/given 3
  • Adequate opportunity to read before signing 2

Warning letters citing § 50.27

7 FDA warning letters since 2017 cite this section :

FDA guidance that cites § 50.27

Amendment history

Federal Register documents that created or amended this section.